Literature DB >> 29670929

Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention.

Philipp A Steininger1, Tobias Bobinger2, Wenke Dietrich3, De-Hyung Lee2, Michael Knott4, Christian Bogdan5, Klaus Korn1, Roland Lang5.   

Abstract

Rituximab (RTX) has become a standard therapy for certain B cell malignancies and autoimmune diseases. We report 2 RTX-treated patients who developed severe tick-borne encephalitis virus (TBEV) infection. The inability to generate new antibody responses renders RTX-treated patients susceptible to TBEV, impedes laboratory diagnosis, and necessitates preventive vaccination in endemic areas.

Entities:  

Keywords:  B cell depletion; immunoglobulins; tick-borne encephalitis; vaccination

Year:  2017        PMID： 29670929      PMCID： PMC5903409          DOI： 10.1093/ofid/ofx204

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  15 in total

1.  Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy.

Authors:  Ilaria Caracciolo; Matteo Bassetti; Giorgio Paladini; Roberto Luzzati; Daniela Santon; Maria Merelli; Giovanni De Sabbata; Tea Carletti; Alessandro Marcello; Pierlanfranco D'Agaro
Journal:  J Clin Virol       Date:  2015-05-29       Impact factor: 3.168

2.  Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab.

Authors:  Ann Knight; Karlis Pauksens; Gunnel Nordmark; Eva Kumlien
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

3.  Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.

Authors:  Philip O Rabel; Christina B Planitzer; Maria R Farcet; Thomas R Kreil
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

4.  A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting.

Authors:  Dariusz Lipowski; Marta Popiel; Karol Perlejewski; Shota Nakamura; Iwona Bukowska-Osko; Ewa Rzadkiewicz; Tomasz Dzieciatkowski; Anna Milecka; Wojciech Wenski; Michal Ciszek; Alicja Debska-Slizien; Ewa Ignacak; Kamila Caraballo Cortes; Agnieszka Pawelczyk; Andrzej Horban; Marek Radkowski; Tomasz Laskus
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 5.  Tick-borne encephalitis.

Authors:  Lars Lindquist; Olli Vapalahti
Journal:  Lancet       Date:  2008-05-31       Impact factor: 79.321

6.  Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA.

Authors:  Michaela Schwaiger; Pascal Cassinotti
Journal:  J Clin Virol       Date:  2003-07       Impact factor: 3.168

Review 7.  Anti-B cell antibody therapies for inflammatory rheumatic diseases.

Authors:  Mikkel Faurschou; David R W Jayne
Journal:  Annu Rev Med       Date:  2013-10-18       Impact factor: 13.739

8.  Persistent and relapsing babesiosis in immunocompromised patients.

Authors:  Peter J Krause; Benjamin E Gewurz; David Hill; Francisco M Marty; Edouard Vannier; Ivo M Foppa; Richard R Furman; Ellen Neuhaus; Gail Skowron; Shaili Gupta; Carlo McCalla; Edward L Pesanti; Mary Young; Donald Heiman; Gunther Hsue; Jeffrey A Gelfand; Gary P Wormser; John Dickason; Frank J Bia; Barry Hartman; Sam R Telford; Diane Christianson; Kenneth Dardick; Morton Coleman; Jennifer E Girotto; Andrew Spielman
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

9.  Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Authors:  Anna Grankvist; Per-Ola Andersson; Mattias Mattsson; Monica Sender; Krista Vaht; Linnea Höper; Egidija Sakiniene; Estelle Trysberg; Martin Stenson; Jan Fehr; Sona Pekova; Christian Bogdan; Guido Bloemberg; Christine Wennerås
Journal:  Clin Infect Dis       Date:  2014-03-18       Impact factor: 9.079

10.  West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature.

Authors:  Sejal Morjaria; Esther Arguello; Ying Taur; Kent Sepkowitz; Vaios Hatzoglou; Ajay Nemade; Marc Rosenblum; Marcela S Cavalcanti; M Lia Palomba; Anna Kaltsas
Journal:  Open Forum Infect Dis       Date:  2015-09-19       Impact factor: 3.835
View more
  2 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

2. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.